EMERGENT BIOSOLUTIONS INC (EBS) Stock News

USA - NYSE:EBS - US29089Q1058 - Common Stock

12.48 USD

-0.36 (-2.8%)

Last: 10/31/2025, 8:04:00 PM

12.19 USD

-0.29 (-2.32%)

After Hours: 10/31/2025, 8:04:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

EBS Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Chartmill - Mentions: FMC FMFC GCI HBIO ...

News Image

These stocks are moving in today's session

3 days ago - By: Chartmill - Mentions: FMC FMFC HBIO SFM ...

News Image

Here are the top movers in Thursday's session.

3 days ago - By: Zacks Investment Research - Mentions: VCEL

Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out?

3 days ago - By: The Motley Fool

Emergent BioSolutions (EBS) Earnings Transcript

3 days ago - By: Benzinga - Mentions: HBIO IART GH INTS ...

12 Health Care Stocks Moving In Thursday's Intraday Session

4 days ago - By: Chartmill - Mentions: FMC FMFC IART HBIO ...

News Image

The market is filled with gapping stocks in Thursday's session.

4 days ago - By: Stocktwits

Retail Traders Turn Ultra-Bullish On Emergent BioSolutions After Surprise Q3 Profit

4 days ago - By: Zacks Investment Research - Mentions: NTLA

Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates

4 days ago - By: Chartmill - Mentions: FMC WOLF CMG SFM ...

News Image

What's going on in today's after hours session

4 days ago - By: Emergent BioSolutions

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

4 days ago - By: Emergent BioSolutions

Emergent BioSolutions Reports Third Quarter 2025 Financial Results

5 days ago - By: Benzinga - Mentions: CGO ROL ESRT NNBR ...

Earnings Scheduled For October 29, 2025

6 days ago - By: Emergent BioSolutions

Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness

26 days ago - By: Emergent BioSolutions

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

26 days ago - By: Emergent BioSolutions

Emergent BioSolutions to Report Third Quarter 2025 Financial Results on October 29, 2025

a month ago - By: Emergent BioSolutions

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

a month ago - By: Emergent BioSolutions

Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone

a month ago - By: Stocktwits - Mentions: IWMW AVSU

Emergent BioSolutions Stock Rises After Receiving Fresh International Purchase Orders: Retail Says Stock Is ‘Significantly Undervalued’

a month ago - By: Emergent BioSolutions

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

a month ago - By: Emergent BioSolutions

Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions to Participate in Upcoming Investor Conferences

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions to Participate in Upcoming Investor Conferences

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

2 months ago - By: Emergent BioSolutions

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™